Co-founder of NoRD Bio Inc and director of data science.
My expertise is in the intersection of statistical models and real world data. I have worked at the Broad Institute of MIT and Harvard studying cancer heterogeneity and treatment resistance, and defended my doctorate in Bayesian experimental design at Columbia University.
Publication Spotlight
(full
list indexed on
Google Scholar)
 |
Growth dynamics in naturally progressing chronic
lymphocytic leukaemia *
We analysed the indolent growth
of CLL by reconstruction of the diseased cell population
from DNA sequencing data. This analysis was made
possible by our Bayesian clustering tool
PhylogicNDT.
|
 |
Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment *
This paper is a comprehesive presentation of
PhylogicNDT.
We have used it to reconstruct the trajectory of tumor growth in lung adenocarcinoma.
While every feature is individually showcased in other,
high
profile
peer-reviewed publictations, this remains the best reference.
|
* co-first author
You can connect with me on Linkedin.
I am a proud member of iCons alumni
network at the UMass Amherst.
Thank you
iCons faculty and alumni for making this program possible!